PON1 arylesterase activity correlated negatively with chemerin concentration when analysing the whole study population or the NDO individuals, which indicates the impact of obesity on antioxidant capacity even in the absence of manifest insulin resistance or cardiovascular complications. This evidence concerns the gene PON1 and obesity disorder.